Who Owns PDSB?

PDS Biotechnology Corporation — Institutional Ownership & 13F Holdings

$0.92

+0.03 (+3.05%)

Market Cap

$37.5M

Shares Outstanding

55,815,653

Institutional Holders

46

Total Inst. Value

$10.0M

% of Float Held

QoQ Holder Change

-15

Institutional data as of Q1 2025

New Positions

10

Closed Positions

13

Increased

11

Decreased

12

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ARMISTICE CAPITAL, LLCNew$5.3M4,419,000
2VANGUARD GROUP INC$1.8M1,510,221
3BlackRock, Inc.$581K488,033
4GEODE CAPITAL MANAGEMENT, LLC$520K437,881
5BLAIR WILLIAM & CO/IL$306K257,200
6NORTHWESTERN MUTUAL WEALTH MANAGEMENT CONew$306K257
7UBS Group AG$299K251,156
8STATE STREET CORP$158K133,333
9COMMONWEALTH EQUITY SERVICES, LLC$110K92,030
10NORTHERN TRUST CORP$98K82,532

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold PDSB?

As of Q1 2025, 46 institutional investors report holding PDSB (PDS Biotechnology Corporation) in their 13F filings.

Which hedge fund owns the most PDSB?

The largest institutional holder of PDSB is ARMISTICE CAPITAL, LLC with $5.3M in shares.

Are institutions buying or selling PDSB?

This quarter, 10 institutions opened new positions in PDSB and 13 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.